These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 25237831)
1. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. Lu J; Zhao FP; Peng Z; Zhang MW; Lin SX; Liang BJ; Zhang B; Liu X; Wang L; Li G; Tian WD; Peng Y; He ML; Li XP Oncotarget; 2014 Nov; 5(22):11319-32. PubMed ID: 25237831 [TBL] [Abstract][Full Text] [Related]
3. Let-7a inhibits proliferation and induces apoptosis by targeting EZH2 in nasopharyngeal carcinoma cells. Cai K; Wan Y; Sun G; Shi L; Bao X; Wang Z Oncol Rep; 2012 Dec; 28(6):2101-6. PubMed ID: 22972404 [TBL] [Abstract][Full Text] [Related]
4. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Alajez NM; Shi W; Hui AB; Bruce J; Lenarduzzi M; Ito E; Yue S; O'Sullivan B; Liu FF Cell Death Dis; 2010 Oct; 1(10):e85. PubMed ID: 21368858 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. Li X; Lin Y; Yang X; Wu X; He X Biochem Biophys Res Commun; 2016 May; 473(4):913-919. PubMed ID: 27040767 [TBL] [Abstract][Full Text] [Related]
6. Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis. Zhang K; Liu D; Zhao J; Shi S; He X; Da P; You Y; You B Cell Death Dis; 2021 May; 12(6):554. PubMed ID: 34050127 [TBL] [Abstract][Full Text] [Related]
7. Enhancer of zeste homolog 2 overexpression in nasopharyngeal carcinoma: an independent poor prognosticator that enhances cell growth. Hwang CF; Huang HY; Chen CH; Chien CY; Hsu YC; Li CF; Fang FM Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):597-604. PubMed ID: 21300475 [TBL] [Abstract][Full Text] [Related]
8. EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis. Zhang P; Garnett J; Creighton CJ; Al Sannaa GA; Igram DR; Lazar A; Liu X; Liu C; Pollock RE J Pathol; 2014 Feb; 232(3):308-18. PubMed ID: 24132643 [TBL] [Abstract][Full Text] [Related]
9. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Lu J; He ML; Wang L; Chen Y; Liu X; Dong Q; Chen YC; Peng Y; Yao KT; Kung HF; Li XP Cancer Res; 2011 Jan; 71(1):225-33. PubMed ID: 21199804 [TBL] [Abstract][Full Text] [Related]
10. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2. Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176 [TBL] [Abstract][Full Text] [Related]
11. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2. Liu F; He Y; Shu R; Wang S Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190 [TBL] [Abstract][Full Text] [Related]
13. Clinical and biological significance of HAX-1 overexpression in nasopharyngeal carcinoma. You B; Cao X; Shao X; Ni H; Shi S; Shan Y; Gu Z; You Y Oncotarget; 2016 Mar; 7(11):12505-24. PubMed ID: 26871467 [TBL] [Abstract][Full Text] [Related]
14. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Shu XS; Li L; Ji M; Cheng Y; Ying J; Fan Y; Zhong L; Liu X; Tsao SW; Chan AT; Tao Q Carcinogenesis; 2013 Sep; 34(9):1984-93. PubMed ID: 23677067 [TBL] [Abstract][Full Text] [Related]
15. MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2. Sun J; Zheng G; Gu Z; Guo Z J Neurooncol; 2015 May; 122(3):481-9. PubMed ID: 25939439 [TBL] [Abstract][Full Text] [Related]